At the DNA level, the frequency of RIPK2 copy number amplification or gain increases along with PC progression, ranging from 12.3% in low-grade, low-risk PC to 64.6% in mCRPC (Fig. 1c and Supplementary Fig. 1b). The gene discussed is RIPK2; the disease is pachyonychia congenita.